| Clinical review: drug metabolism and nonrenal clearance in acute kidney injury AM Vilay, MD Churchwell, BA Mueller Critical care 12, 1-9, 2008 | 100 | 2008 |
| Daptomycin clearance during modeled continuous renal replacement therapy MD Churchwell, DA Pasko, BA Mueller Blood purification 24 (5-6), 548-554, 2006 | 82 | 2006 |
| Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis MD Churchwell, DA Pasko, WE Smoyer, BA Mueller Nephrology Dialysis Transplantation 24 (1), 231-238, 2009 | 69 | 2009 |
| The clinical application of CRRT—current status: drug dosing during continuous renal replacement therapy MD Churchwell, BA Mueller Seminars in dialysis 22 (2), 185-188, 2009 | 66 | 2009 |
| Trace element removal during in vitro and in vivo continuous haemodialysis MD Churchwell, DA Pasko, IF Btaiche, JC Jain, BA Mueller Nephrology Dialysis Transplantation 22 (10), 2970-2977, 2007 | 58 | 2007 |
| Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysis NN Salama, JH Segal, MD Churchwell, JH Patel, L Gao, M Heung, ... Clinical Journal of the American Society of Nephrology 4 (7), 1190-1194, 2009 | 43 | 2009 |
| Single-dose daptomycin pharmacokinetics in chronic haemodialysis patients NN Salama, JH Segal, MD Churchwell, JH Patel, L Gao, M Heung, ... Nephrology dialysis transplantation 25 (4), 1279-1284, 2010 | 42 | 2010 |
| Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy DA Pasko, MD Churchwell, NN Salama, BA Mueller Blood purification 32 (2), 82-88, 2011 | 38 | 2011 |
| Ertapenem clearance during modeled continuous renal replacement therapy JM Stevenson, JH Patel, MD Churchwell, AM Vilay, DD Depestel, ... The International Journal of Artificial Organs 31 (12), 1027-1034, 2008 | 31 | 2008 |
| Continuous venovenous hemodiafiltration trace element clearance in pediatric patients: a case series DA Pasko, MD Churchwell, IF Btaiche, JC Jain, BA Mueller, ... Pediatric Nephrology 24, 807-813, 2009 | 28 | 2009 |
| Modeled dalbavancin transmembrane clearance during intermittent and continuous renal replacement therapies AM Vilay, KH Shah, MD Churchwell, JH Patel, DD DePestel, BA Mueller Blood purification 30 (1), 37-43, 2010 | 25 | 2010 |
| Physical compatibility of 4% sodium citrate with selected antimicrobial agents B Dotson, S Lynn, K Savakis, MD Churchwell American Journal of Health-System Pharmacy 67 (14), 1195-1198, 2010 | 23 | 2010 |
| Novel therapeutic agents for the treatment of diabetic kidney disease RE Hartman, PSS Rao, MD Churchwell, SJ Lewis Expert Opinion on Investigational Drugs 29 (11), 1277-1293, 2020 | 21 | 2020 |
| Telavancin and Hydroxy Propyl-β-Cyclodextrin Clearance during Continuous Renal Replacement Therapy: An in vitro Study JH Patel, MD Churchwell, JD Seroogy, SL Barriere, M Grio, BA Mueller The International Journal of Artificial Organs 32 (10), 745-751, 2009 | 18 | 2009 |
| Use of an in vitro model of renal replacement therapy systems to estimate extracorporeal drug removal MD Churchwell The Journal of Clinical Pharmacology 52 (S1), 35S-44S, 2012 | 16 | 2012 |
| Selected pharmacokinetic issues in patients with chronic kidney disease MD Churchwell, BA Mueller Blood purification 25 (1), 133-138, 2006 | 16 | 2006 |
| Hemodialysis and peritoneal dialysis KM Sowinski, MD Churchwell, BS Decker Pharmacotherapy–A Pathophysiologic approach. 9th ed. New York: McGraw Hill …, 2014 | 9 | 2014 |
| Telavancin transmembrane clearance during in vitro continuous venovenous hemofiltration JH Patel, MC Grio, MD Churchwell, J Seroogy, S Barriere, BA Mueller 16th European Congress of Clinical Microbiology and Infectious Diseases …, 2006 | 8 | 2006 |
| A student-inclusive pharmacotherapeutics textbook selection process MJ Peeters, MD Churchwell, LS Mauro, DM Cappelletty, GE Stone Currents in Pharmacy Teaching and Learning 2 (1), 31-38, 2010 | 7 | 2010 |
| Compatibility of conivaptan injection with select cardiovascular medications VF Mauro, MS Howard, SHS Boddu, MD Churchwell American Journal of Health-System Pharmacy 71 (18), 1534-1535, 2014 | 6 | 2014 |
Bruce A. MuellerProfessor of Pharmacy, University of MichiganVerified email at umich.edu
